USC study pinpoints early window in craniosynostosis development

Researchers at the University of Southern California identified a postnatal developmental window when excess FGFR2 signaling can trigger premature coronal suture fusion in mice. The findings link a FGFR2-P38-retinoic acid pathway to skull growth, intracranial pressure and neurocognitive deficits, pointing to a possible treatment target.

Why it matters: - Craniosynostosis can restrict skull growth, raise intracranial pressure, and affect neurocognitive development. - The study suggests that when FGFR2 signaling turns abnormal may matter as much as the mutation itself. - The results point to retinoic acid signaling as a possible therapeutic target for FGFR2-associated craniosynostosis.

What happened: - University of Southern California researchers studied postnatal coronal suture development in FGFR2-associated craniosynostosis. - The team published the study in the International Journal of Oral Science on Aug. 17, 2026. - Researchers examined GLI1+ progenitor cells and their interaction with the dura mater. - The work tested whether retinoic acid signaling acts downstream of FGFR2 and whether restoring that pathway could prevent or reverse disease-related changes.

The details: - Researchers used genetically engineered mice to overactivate FGFR2 in GLI1+ progenitor cells at different postnatal stages. - The team used histology, microCT, intracranial pressure measurements, and reporter models to track suture fusion and progenitor-cell changes. - RNA sequencing identified altered signaling pathways. - Co-culture experiments, P38 inhibition, and Aldh1a3 reduction were used to probe the FGFR2-P38-retinoic acid pathway. - Suture regeneration and behavioral testing assessed whether restoring suture patency or retinoic acid signaling could improve structural and neurocognitive outcomes. - FGFR2 overactivation at postnatal day 3.5, but not day 7.5, caused premature coronal suture fusion. - Excess FGFR2 signaling reduced GLI1+ progenitors and pushed them toward osteoblast differentiation. - RNA sequencing showed increased Rbp1 and Aldh1a3 expression, supporting higher retinoic acid production. - FGFR2 activated P38 MAPK, which increased retinoic acid synthesis in the dura mater and suture mesenchyme. - Lowering Aldh1a3 restored GLI1+ progenitors, reduced abnormal bone formation, preserved suture patency, improved skull shape, and lowered intracranial pressure. - Suture regeneration or retinoic acid restoration also improved neurocognitive deficits in mutant mice.

Between the lines: - The findings suggest a narrow developmental window when the postnatal coronal suture is vulnerable to FGFR2-driven fusion. - The study also suggests that the reported brain and behavior effects may stem mainly from skull restriction and elevated intracranial pressure, not direct neural effects of the mutation. - That distinction matters for therapy design because restoring skull growth may address both structural and cognitive outcomes.

What's next: - Future work will test how P38-regulated transcription factors control retinoic acid synthesis genes. - Researchers also want to know whether targeting this pathway can safely prevent or treat FGFR2-associated craniosynostosis. - The study's authors say early, time-sensitive intervention could be important if the pathway proves clinically useful.

The bottom line: - USC researchers mapped a time-sensitive FGFR2-P38-retinoic acid pathway that helps determine whether the coronal suture stays open or fuses too early. - The work provides a potential route to prevent craniosynostosis-related skull and neurocognitive damage.